Bevacizumab extends survival for relapsed and advanced cervical cancer
Bevacizumab extends survival for relapsed and advanced cervical cancer
Lapatinib in combination with chemotherapy in breast cancer
Comment on biennial visual inspection with acetic acid (VIA), or vinegar
Cetuximab superior to bevacizumab for advanced colorectal cancer
Improving outcomes of childhood neuroblastoma
Nivolumab produces long-lasting responses in patients with stage IV melanoma
Delayed relapse of advanced ovarian cancer when treating with pazopanib
Cetuximab superior to bevacizumab for advanced colorectal cancer
Spouses of patients with HPV-positive oropharyngeal cancer do not have increased oral HPV infections
Maintenance therapy with multi-targeted drug pazopanib delays relapse of advanced ovarian cancer
Adding GM-CSF to ipilimumab improves survival compared to ipilimumab alone
Profiles of malignant GCTs and potential biomarkers for CNS germ cell tumours